Skip to content

Effects of drinking tea containing ginseng on human.

Effects of drinking tea containing ginseng on human. - Ginseng tea clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023348
Enrollment
40
Registered
2017-10-29
Start date
2016-07-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy people

Interventions

ginseng tea 2 packs/day Placebo tea 2 packs/day

Sponsors

Kindai University Department of Biological & Environmental Chemistry Faculty of Human-Oriented Science and Engineering
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) non smokers (2) persons who will generally be judged as healthy (3) persons who have never suffered from asthma (4) persons who have never developed any allegic reaction to medicines, foods, or other substances. (5) Persons who will give written informed consent by themselves.

Exclusion criteria

Exclusion criteria: (1) persons who have any dietary supplements, quasi drugs or medicines which cause same or similar efficacy with the effect evaluated in this study (2) persons who changed their habitats of supplements with in 4 weeks. (3) Persons who work in night shift or in day and night shift (4) persons who have been treated their illness or prevention in a clinic at their informed consent (5) persons with their medical histories as follows: serious diseases of Sugar metabolism,lipid metabolism, liver function, renal function, heart, circulatory, respiratory, endocrine system, immune system, or mental illness of the nervous system (6) persons with the medical histories of alcoholism or drug dependence (7) persons who might be developed allergic reaction to foods. (8) Persons who are pregnant, breast-feeding, or hope to be pregnant during the study period (9) persons who had always participated in or will participate in any other clinical trial (to use foods/medicine/quasi medicine/medical device) (10) persons who will not be judged suitable to the participants by the investigator.

Design outcomes

Primary

MeasureTime frame
Evaluating the cognitive function using HDS-R, Standard verbal paired-associate learning test, and Benton Visual Retention Test after 4 and 12 weeks after the start of the administration.

Countries

Japan

Contacts

Public ContactKoichiro Ohnuki

Kindai University Department of Biological & Environmental

ohnuki@fuk.kindai.ac.jp0948-22-5655

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026